STAT2 and lung adenocarcinoma: Based on our finding that STAT2 preferentially inhibits the induction of IRF3-dependent genes, we propose that the IKKi-induced T404 phosphorylation of STAT2 mediates tumor progression in lung adenocarcinoma by inhibiting the tumor-suppressive function of the cGAS–STING pathway.